Mesenchymal Stem Cells

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Recovery Following Partial Medial Meniscectomy

Drug Information

Target Indication

Recovery Following Partial Medial Meniscectomy

Clinical Trial

Last updated: 2/7/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

ISCO

International Stem Cell CORP

Related Pipeline

Monocarboxylate Transporter 8 Deficiency

Dravet Syndrome

Refractory Schizophrenia

Knee Osteoarthritis

Head Lice